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Over 18% of people aged 60–75 years have diabetes, which represents 35% of diabetes prevalence in adults 
(International Diabetes Federation [IDF], 2013). 
Diabetes is a leading cause of death in older people. 
Although there are differences in life expectancy 
among countries, most countries have an ageing 
population. Increasing age is a risk factor for 
diabetes, but the presentation is often atypical and 
the diagnosis can be missed or attributed to causes 
other than diabetes, including “old age”.  
Diabetes differs metabolically between older 
and younger people. Fasting plasma glucose (FPG) 
is not usually increased in older people with type 
2 diabetes (T2D; Amer et al, 1991; Meneilly and 
Elliott, 1999). Thus, FPG might not be the optimal 
diagnostic test in older people. Insulin action is 
relatively normal in lean older people with T2D, 
but insulin secretion can be impaired; overweight 
older people have significant insulin resistance and 
relatively normal insulin secretion (Meneilly, 2011). 
Consequently, management strategies need to target 
the underlying metabolic disturbance. Lean older 
people are likely to need insulin at, or soon after 
diagnosis; overweight older people might benefit 
initially from insulin-sensitising medicines, such as 
metformin.
The renal threshold increases with age and, 
consequently, glycosuria might not occur until the 
blood glucose is very high. Older people often do not 
recognise thirst and might not drink enough fluid to 
compensate for fluid loss. Thus, it is important that 
health professionals undertake relevant risk screening 
in older people, for example, during annual 
health checks, hospital admissions, or when the 
individual presents with an infection, slow healing 
wounds, a diabetes complication or hyperosmolar 
hyperglycaemic states (HHS).
Comorbidities
The risk of complications increases with persistent 
hyperglycaemia and longer duration of diabetes 
(Meneilly, 2011). Complications contribute to 
physical, cognitive, sensory and functional decline, 
which compromise independence, memory, 
self-care capacity and quality of life (Kirkman et 
al, 2012). There is an association between vascular 
dementia and Alzheimer’s disease and diabetes 
(Tolppanen et al, 2013), and severe hypoglycaemia 
in T2D is associated with dementia risk (Whitmer, 
2009; Yaffe et al, 2013). In addition, older people 
with diabetes have high rates of depression (Cahoon 
2012), which often coexists with dementia.
Older people commonly present with geriatric 
syndromes and delirium. Symptoms include 
confusion, difficulty focusing, hallucinations, 
disorientation and “personality change”, for 
example, agitation and irritability. Diabetes-related 
predisposing factors to delirium include 
cardiovascular and renal disease, infections, 
hypoglycaemia, and electrolyte changes associated 
with some medicines, hyperglycaemia and HHS.
Key care principles
Optimal care must be holistic, person-centred 
and suit the individual’s social situation and 
support systems. Where possible, management 
options should decided in partnership with the 
individual and/or their carers. Maintaining safety, 
independence, functional status and quality of life 
by reducing the symptom and medicine burden 
is important. Consequently, pharmacovigilance is 
vital (Sinclair et al, 2012; Dunning et al, 2013). A 
comprehensive care plan should encompass:
l A proactive risk assessment process to identify 
conditions, such as nutritional deficiencies and 
increasing frailty. Identification of hypoglycaemia 
and hyperglycaemia is important to reduce risk 
of pain, falls, geriatric syndromes, delirium and 
depression, which can compromise functional 
status.
l Assessing risk/benefit, functional status and life 
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expectancy when deciding management strategies 
initially and when changing management.
l Appropriate management goals and targets suited 
to the individual’s health and functional status.
l Regular reassessment of the individual and their 
care plan; for example during annual health 
and diabetes complication assessments. This is 
particularly important when their health status or 
treatment regimen changes.
l Plans to stop driving may be necessary and end of 
life plans.
l Assessment, and reduction of, cardiovascular risk 
as early and effectively as possible with a healthy 
diet and exercise, lipid-lowering agents, aspirin and 
antihypertensive agents. 
l Managing hyperglycaemia to manage symptoms, 
promote comfort, reduce the risk of cardiovascular 
and microvascular disease, prevent dehydration 
and consequent risk of ketoacidosis, HHS, falls, 
pain, delirium and depression.  
l An appropriate sick day care plan that suits 
the individual and is revised when the person’s 
self-care capacity declines.
l General health screening.
l Support for family carers and involving them in 
care decisions where possible.
Pharmacovigilance
Many commonly prescribed medicines should be 
avoided or used with caution in older people, for 
example, sliding insulin scales (American Geriatrics 
Society, 2012). Regular blood glucose testing can 
guide decisions about the medicine regimen.
Pharmacovigilance includes:
l Selecting medicines based on a comprehensive 
assessment that includes renal and liver function, 
allergies, nutritional status and medicine 
contraindications and cautions.
l Using the lowest effective dose in the simplest dose 
regimen to avoid polypharmacy and selecting a 
dose suited to the individual.
l Avoiding or discontinuing medicines that are 
contraindicated, or should be used with caution in 
older people. The use of screening tools is useful, 
for example, Beers Criteria (American Geriatrics 
Society, 2012); Screening tool of older persons’ 
potentially inappropriate prescriptions (STOPP; 
Gallagher and O’Mahony, 2008) and Screening 
tool to alert doctors to right but often omitted 
treatments (START; Barry et al, 2007).
l Using non-medicine options where possible.
l Regular comprehensive medicine reviews.
l Effective communication processes and current 
medicine lists, especially when there are multiple 
prescribers.  
l Implementing medical alerts to enhance safety 
when the individual is transferred among different 
care services.
Summary
Managing older people with diabetes is complex. 
Hyperglycaemia and hypoglycaemia symptoms 
are often atypical and under-recognised. Physical, 
sensory and cognitive changes are common 
and can affect self-care ability and compromise 
safety. Delirium and geriatric syndromes must be 
considered, and pharmocovigilance is essential. Care 
must be individualised, holistic and communicated 
in a way that is understandable. Proactive planning, 
such as stopping driving, planning end-of-life care 
and moving into supported care facilities, can help 
mitigate the stress associated with these events. n
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“Care must be 
individualised, holistic 
and communicated 
in a way that is 
understandable.”
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